Total body irradiation for patients before stem cell transplants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients undergoing total body irradiation (TBI) as part of their preparation for bone marrow or peripheral stem cell transplantation. TBI is utilized to suppress the immune system and eliminate remaining cancer cells after chemotherapy. The study aims to collect and analyze data from these treatments to improve understanding of their effectiveness and tolerance. By gathering information from a diverse patient population, the research seeks to identify optimal treatment parameters and clinical situations that enhance patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients undergoing total body irradiation as candidates for bone marrow or peripheral stem cell transplantation.
2. Signed informed consent

Exclusion Criteria:

* Patients who do not undergo total body irradiation

Where it's running

• European Institute of Oncology
  Milan, Italy Recruiting

Study contacts

• Principal investigator: Barbara Alicja Jereczek — European Institute of Oncology
• Study coordinator: Barbara Alicja Jereczek
• Email: barbara.jereczek@ieo.it
• Phone: +39 02 57489326

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau

  This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07205523

• Long-term study of blood diseases in patients in China

  This study is trying to gather detailed information from patients in China with blood diseases like leukemia and multiple myeloma to better understand how these conditions affect their lives and treatment options.

  Recruiting Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT04645199

• Genetics of Blood Cancers in the U.S. population

  This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.

  Recruiting Rutgers, The State University of New Jersey · Piscataway, New Jersey · NCT07714044

• Cord blood transplant for children and young adults with blood cancers.

  This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.

  Recruiting Phase 2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT07566377

• Capivasertib plus venetoclax with low-intensity chemotherapy for adults with lymphoid acute leukemia or lymphoblastic lymphoma

  This will see if adding capivasertib to venetoclax and a low‑intensity chemotherapy regimen helps adults with relapsed or refractory lymphoid acute leukemia or lymphoblastic lymphoma.

  Recruiting Phase 1/2 University of Chicago · Chicago, Illinois · NCT07294677

• Reduced‑dose apixaban or rivaroxaban versus daily low‑molecular‑weight heparin for people with blood cancers

  This trial will test whether reduced‑dose apixaban or rivaroxaban pills can prevent blood clots as well and as safely as daily low‑molecular‑weight heparin injections in people with hematologic malignancies.

  Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT07270263

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.